Prioritizing Patient Experiences in the Management of Diabetes and Its Complications

An Endocrine Society Position Statement

Kalyani, Rita R
Allende-Vigo, Myriam Z
Antinori-Lent, Kellie J
Close, Kelly L
Das, Sandeep R
Deroze, Phyllisa
Edelman, Steven V
El Sayed, Nuha A
Kerr, David
Neumiller, Joshua J
Norton, Anna

Division of Endocrinology, Diabetes, & Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Endocrine Section, University of Puerto Rico, San Juan 00936, Puerto Rico
UPMC Shadyside, Pittsburgh, PA 15213, USA
Close Concerns Inc, San Francisco, CA 94117, USA
Division of Cardiology, UT Southwestern Medical Center, Dallas, TX 75390, USA
dQ&A, The Diabetes Research Company, San Francisco, CA 94117, USA
Division of Endocrinology, Diabetes & Metabolism at the University of California at San Diego, San Diego, CA 92103, USA
American Diabetes Association, Harvard Medical School, Boston, MA 02215, USA
Director of Digital Health, Diabetes Technology Society, Santa Barbara, CA 94010, USA
Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA
DiabetesSisters, #180, 1112 W Boughton Road, Bolingbrook, IL 60440, USA

Correspondence: Rita R. Kalyani, MD, MHS, Division of Endocrinology, Diabetes, & Metabolism, Johns Hopkins University School of Medicine, 1830 E Monument St, Ste 333, Baltimore, MD 21287, USA. Email: [email protected].

Received December 11, 2023

Revised February 21, 2024

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Journal of Clinical Endocrinology & Metabolism 109(5):p 1155-1178, May 2024. | DOI: 10.1210/clinem/dgad745